Diagnostic value of non-invasive bio-markers for stage-specific diagnosis of hepatic fibrosis in patients with advanced schistosomiasis japonica

International Journal for Parasitology

Volumn 41, Issue 3, 2011, Pages 325-332

  Hou, Xun ya ^a   Ellis, Magda K ^b   McManus, Donald P ^b   Wang, Yuan yuan ^a   Li, Shang da ^c   Williams, Gail M ^c   Li, Yue sheng ^a,b  

^a HUNAN INSTITUTE OF PARASITIC DISEASES   (China)

^b QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^c UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Advanced schistosomiasis; Diagnostic test; Fibrosis markers; Hepatic fibrosis stages; Schistosoma japonicum

Indexed keywords

ASPARTATE AMINOTRANSFERASE; HYALURONIC ACID; PLATELET DERIVED GROWTH FACTOR BB; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

BIOMARKER; CONFIDENCE INTERVAL; DISEASE CONTROL; EFFICIENCY MEASUREMENT; LABORATORY METHOD; PARASITIC DISEASE;

ADULT; ARTICLE; CHINA; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DISEASE COURSE; DISEASE SEVERITY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LABORATORY TEST; LIVER BIOPSY; LIVER CIRRHOSIS; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; PREDICTIVE VALUE; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; RECEIVER OPERATING CHARACTERISTIC; REFERENCE VALUE; RELIABILITY; SCHISTOSOMIASIS JAPONICA; SENSITIVITY AND SPECIFICITY; THROMBOCYTE COUNT;

ADULT; ALANINE TRANSAMINASE; AREA UNDER CURVE; ASPARTATE AMINOTRANSFERASES; BIOLOGICAL MARKERS; CHINA; CONFIDENCE INTERVALS; FEMALE; HUMANS; LIVER; LIVER CIRRHOSIS; MALE; MIDDLE AGED; PLATELET COUNT; PLATELET-DERIVED GROWTH FACTOR; ROC CURVE; SCHISTOSOMIASIS JAPONICA; SEVERITY OF ILLNESS INDEX; TISSUE INHIBITOR OF METALLOPROTEINASE-1;

CHINA;

JAPONICA; SCHISTOSOMA; SCHISTOSOMA JAPONICUM;

EID: 79951811415     PISSN: 00207519     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpara.2010.10.007     Document Type: Article

References (57)

1. Arnaud V., Li J., Wang Y., Fu X., Mengzhi S., Luo X., Hou X.Y., Dessein H., Jie Z., Xin-Ling Y., He H., McManus D.P., Li Y.S., Dessein A.D. Regulatory role of interleukin-10 and interferon-gamma in severe hepatic central and peripheral fibrosis in humans infected with Schistosoma japonicum. J. Infect. Dis. 2008, 198:418-426.
2. Anthony B., Allen J.T., Li Y.S., McManus D.P. Hepatic stellate cells and parasite-induced liver fibrosis. Parasit. Vectors. 2010, 3:60.
3. Badra G., Lotfy M., El-Refaie A., Obada M., Abdelmonem E., Kandeel S., Fathy A. Significance of serum matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in chronic hepatitis C patients. Acta Microbiol. Immunol. Hung. 2010, 57:29-42.
4. Bartley P.B., Ramm G.A., Jones M.K., Ruddell R.G., Li Y.S., McManus D.P. A contributory role for activated hepatic stellate cells in the dynamics of Schistosoma japonicum egg-induced fibrosis. Int. J. Parasitol. 2006, 36:993-1001.
5. Boeker K.H., Haberkorn C.I., Michels D., Flemming P., Manns M.P., Lichtinghagen R. Diagnostic potential of circulating TIMP-1 and MMP-2 as markers of liver fibrosis in patients with chronic hepatitis C. Clin. Chim. Acta. 2002, 316:71-81.
6. Bonner J.C. Regulation of PDGF, its receptors in fibrotic diseases. Cytokine Growth Factor Rev 2004, 15:255-273.
7. Burke M.L., Jones M.K., Gobert G.N., Li Y.S., Ellis M.K., McManus D.P. Immunopathogenesis of human schistosomiasis. Parasit0065 Immunol. 2009, 31:163-176.
8. Burke M.L., McManus D.P., Ramm G.A., Duke M., Li Y.S., Jones M.K., Gobert G.N. Temporal expression of chemokines dictates the hepatic inflammatory infiltrate in a murine model of schistosomiasis. PLoS. Negl. Trop. Dis. 2010, 4:e598.
9. Cheever A.W. Schistosoma japonicum: the pathology of experimental infection. Exp. Parasitol. 1985, 59:l-11.
10. Chen M.G. Use of praziquantel for clinical treatment and morbidity control of schistosomiasis japonica in China: a review of 30 years' experience. Acta Trop. 2005, 96:168-176.
11. Chen M.G., Mott K.E. Progress in assessment of morbidity due to Schistosoma japonicum infection: a review of recent literature. Trop. Dis. Bull. 1988, 85:R1-R45.
12. Chiavaroli R., Grima P., Grima P. Detection of early liver fibrosis in patients with intestinal schistosomiasis: sonographic and histologic findings in Schistosoma mansoni infection. Infection 2008, 36:585-589.
13. Chitsulo L., Engels D., Montresor A., Savioli L. The global status of schistosomiasis and its control. Acta Trop. 2000, 77:41-51.
14. Czochra P., Klopcic B., Meyer E., Herkel J., Garcia-Lazaro J.F., Thieringer F., Schirmacher P., Biesterfeld S., Galle P.R., Lohse A.W., Kanzler S. Liver fibrosis induced by hepatic overexpression of PDGF-B in transgenic mice. J. Hepatol. 2006, 45:419-428.
15. Di Sario A., Bendia E., Svegliati-Baroni G., Marzioni M., Ridolfi F., Trozzi L., Ugili L., Saccomanno S., Jezequel A.M., Benedetti A. Rearrangement of the cytoskeletal network induced by platelet-derived growth factor in rat hepatic stellate cells: role of different intracellular signalling pathways. J. Hepatol. 2002, 36:179-190.
16. Ellis M.K., Li Y.S., Hou X.Y., Chen H., McManus D.P. TNFR-II and sICAM-1 are associated with acute disease and hepatic inflammation in schistosomiasis japonica. Int. J. Parasitol. 2008, 38:717-723.
17. Failli P., De F.R., Caligiuri A., Gentilini A., Romanelli R.G., Marra F., Batignani G., Guerra C.T., Laffi G., Gentilini P., Pinzani M. Nitrovasodilators inhibit platelet-derived growth factor-induced proliferation and migration of activated human hepatic stellate cells. Gastroenterology. 2000, 119:479-492.
18. Fontana R.J., Goodman Z.D., Dienstag J.L., Bonkovsky H.L., Naishadham D., Sterling R.K., Su G.L., Ghosh M., Wright E.C. Relationship of serum fibrosis markers with liver fibrosis stage and collagen content in patients with advanced chronic hepatitis C. Hepatology. 2008, 47:789-798.
19. Friedman L.S. Controversies in liver biopsy: who, where, when, how, why?. Curr. Gastroenterol. Rep. 2004, 6:30-36.
20. Gangadharan B., Antrobus R., Dwek R.A., Zitzmann N. Novel serum biomarker candidates for liver fibrosis in hepatitis C patients. Clin. Chem. 2007, 53:1792-1799.
21. Giannini E., Risso D., Botta F., Chiarbonello B., Fasoli A., Malfatti F., Romagnoli P., Testa E., Ceppa P., Testa R. Validity and clinical utility of the aspartate aminotransferase-alanine aminotransferase ratio in assessing disease severity and prognosis in patients with hepatitis C virus-related chronic liver disease. Arch. Intern. Med. 2003, 163:218-224.
22. Guechot J., Laudat A., Loria A., Serfaty L., Poupon R., Giboudeau J. Diagnostic accuracy of hyaluronan and type III procollagen amino-terminal peptide serum assays as markers of liver fibrosis in chronic viral hepatitis C evaluated by ROC curve analysis. Clin. Chem. 1996, 42:558-563.
23. Hatz C.F. The use of ultrasound in schistosomiasis. Adv. Parasitol. 2001, 48:225-284.
24. Ho A.S., Cheng C.C., Lee S.C., Liu M.L., Lee J.Y., Wang W.M., Wang C.C. Novel biomarkers predict liver fibrosis in hepatitis C patients: alpha 2 macroglobulin, vitamin D binding protein and apolipoprotein AI. J. Biomed. Sci. 2010, 17:58.
25. Imbert-Bismut F., Ratziu V., Pieroni L., Charlotte F., Benhamou Y., Poynard T. Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study. Lancet. 2001, 357:1069-1075.
26. Kinnman N., Hultcrantz R., Barbu V., Rey C., Wendum D., Poupon R., Housset C. PDGF-mediated chemoattraction of hepatic stellate cells by bile duct segments in cholestatic liver injury. Lab. Invest. 2000, 80:697-707.
27. Kmieć Z. Cooperation of liver cells in health and disease. Adv. Anat. Embryol. Cell Biol. 2001, 161(III-XIII):1-151.
28. Köpke-Aguiar L.A., Martins J.R., Passerotti C.C., Toledo C.F., Nader H.B., Borges D.R. Serum hyaluronic acid as a comprehensive marker to assess severity of liver disease in schistosomiasis. Acta Trop. 2002, 84:117-126.
29. Lackner C., Struber G., Liegl B., Leibl S., Ofner P., Bankuti C. Comparison and validation of simple noninvasive tests for prediction of fibrosis in chronic hepatitis C. Hepatology 2005, 41:1376-1382.
30. Lambertucci J.R., Silva L.C., Antunes C.M. Aspartate aminotransferase to platelet ratio index and blood platelet count are good markers for fibrosis evaluation in schistosomiasis mansoni. Rev. Soc. Bras. Med. Trop. 2007, 40:599.
31. Lieber C.S., Weiss D.G., Paronetto F. Value of fibrosis markers for staging liver fibrosis in patients with precirrhotic alcoholic liver disease. Alcohol. Clin. Exp. Res. 2008, 32:1031-1039.
32. Li Y.S., Chen D., Ross A.G., Zhou J., Burke M.L., Yu X., Li R.S., McManus D.P. Severe hepatosplenic schistosomiasis: clinicopathological study of 102 cases undergoing splenectomy. Hum. Pathol. 2011, 42:111-119.
33. McHutchison J.G., Blatt L.M., De Medina M., Craig J.R., Conrad A., Schiff E.R., Tong M.J. Measurement of serum hyaluronic acid in patients with chronic hepatitis C and its relationship to liver histology. Consensus Interferon Study Group. J.Gastroenterol. Hepatol. 2000, 15:945-951.
34. Miele L., Forgione A., La Torre G., Vero V., Cefalo C., Racco S., Vellone V.G., Vecchio F.M., Gasbarrini G., Rapaccini G.L., Neuman M.G., Grieco A. Serum levels of hyaluronic acid and tissue metalloproteinase inhibitor-1 combined with age predict the presence of nonalcoholic steatohepatitis in a pilot cohort of subjects with nonalcoholic fatty liver disease. Transl. Res. 2009, 154:194-201.
35. Murawaki Y., Ikuta Y., Idobe Y., Kitamura Y., Kawasaki H. Tissue inhibitor of metalloproteinase-1 in the liver of patients with chronic liver disease. J. Hepatol. 1997, 26:1213-1219.
36. Myers R.P., Tainturier M.H., Ratziu V., Piton A., Thibault V., Imbert-Bismut F. Prediction of liver histological lesions with biochemical markers in patients with chronic hepatitis B. J. Hepatol. 2003, 39:222-230.
37. Naveau S., Gaudé G., Asnacios A., Agostini H., Abella A., Barri-Ova N., Dauvois B., Prévot S., Ngo Y., Munteanu M., Balian A., Njiké-Nakseu M., Perlemuter G., Poynard T. Diagnostic and prognostic values of non-invasive biomarkers of fibrosis in patients with alcoholic liver disease. Hepatology. 2009, 49:97-105.
38. Pan K., Deng W.C. Diagnosis and intervention of advanced schistosomiasis. The practical control techniques of schistosomiasis 2010, 147-150. Peoples's Medical Publishing House, Beijing. Y.S. Li (Ed.).
39. Parise E.R., Oliveira A.C., Figueiredo-Mendes C., Lanzoni V., Martins J., Nader H., Ferraz M.L. Noninvasive serum markers in the diagnosis of structural liver damage in chronic hepatitis C virus infection. Liver Int. 2006, 26:1095-1099.
40. Pinzani M. PDGF and signal transduction in hepatic stellate cells. Front Biosci. 2002, 7:1720-1726.
41. Poynard T., Morra R., Ingiliz P., Imbert-Bismut F., Thabut D., Messous D., Munteanu M., Massard J., Benhamou Y., Ratziu V. Biomarkers of liver fibrosis. Adv. Clin. Chem. 2008, 46:131-160.
42. Ratziu V., Massard J., Charlotte F., Messousmm D., Imbert-Bismutmm F., Bonyhaym L., Tahiri M., Munteanu M., Thabut D., Cadranel J.F., Le Bail B., de Ledinghen V., Poynard T., LIDO Study Group, CYTOL study group Diagnostic value of biochemical markers (FibroTest-FibroSURE) for the prediction of liver fibrosis in patients with non-alcoholic fatty liver disease. BMC Gastroenterol. 2006, 6:6.
43. Robert Visse., Hideaki Nagase. Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. Circ. Res. 2003, 92:827-839.
44. Ross A.G., Bartley P.B., Sleigh A.C., Olds G.R., Li Y.S., McManus D.P. Schistosomiasis. N. Engl. J. Med. 2002, 346:1212-1220.
45. Shaheen A.A., Myers R.P. Diagnostic accuracy of the aspartate aminotransferase to-platelet ratio index for the prediction of hepatitis C-related fibrosis: a systematic review. Hepatology 2007, 46:912-921.
46. Shen G.J., Jiao M.D., Li Q.Y., Xu H., Han J.M., Yin X.M. Study on histopathology, ultrasonography and some special serum enzymes and collagens for 38 advanced patients of schistosomiasis japonica. Acta Trop. 2002, 82:235-246.
47. Shiha G., Sarin S.K., Ibrahim A.E., Omata M., Kumar A., Lesmana L.A., Leung N., Tozun N., Hamid S., Jafri W., Maruyama H., Bedossa P., Pinzani M., Chawla Y., Esmat G., Doss W., Elzanaty T., Sakhuja P., Nasr A.M., Omar A., Wai C.T., Abdallah A., Salama M., Hamed A., Yousry A., Waked I., Elsahar M., Fateen A., Mogawer S., Hamdy H., Elwakil R. Liver fibrosis: consensus recommendations of the Asian Pacific association for the study of the liver (APASL). Hepatol. Int. 2008, 3:323-333.
48. Singh K.P., Gerard H.C., Hudson A.P., Boros D.L. Dynamics of collagen, MMP and TIMP gene expression during the granulomatous, fibrotic process induced by Schistosoma mansoni eggs. Ann. Trop. Med. Parasitol. 2004, 98:581-593.
49. Soares S., Rodrigues V., Silva D.T., Moraes-Souza H. Participation of platelets in the process of fibrosis in patients with mansonic schistosomiasis. Rev. Soc. Bras. Med. Trop. 2007, 40:321-325.
50. Society of Infectious Disease, Parasitic Disease (SIDPD), CMA Criteria on prevention and treatment for virus hepatitis. Zhonghua Neike Zazhi. 2002, 40:62-68.
51. Suzuki A., Angulo P., Lymp J., Li D., Satomura S., Lindor K. Hyaluronic acid, an accurate serum marker for severe hepatic fibrosis in patients with non-alcoholic fatty liver disease. Liver Int. 2005, 25:779-786.
52. Tangkijvanich P., Melton A.C., Chitapanarux T., Han J., Yee H.F. Platelet-derived growth factor-BB and lysophosphatidic acid distinctly regulate hepatic myofibroblast migration through focal adhesion kinase. Exp. Cell Res. 2002, 281:140-147.
53. Weiner J.A., Chen A., Davis B.H. Platelet-derived growth factor is a principal inductive factormodulating mannose 6-phosphate/insulin-like growth factor-II receptorgene expression via a distal E-box in activated hepatic stellate cells. Biochem. J. 2000, 345(Pt 2):225-231.
54. Wai C.T., Greenson J.K., Fontana R.J., Kalbfleisch J.D., Marrero J.A., Conjeevaram H.S., Lok A.S. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology. 2003, 38:518-526.
55. Wyszomirska R.M., Nishimura N.F., Almeida J.R., Yamanaka A., Soares E.C. High serum laminin and type IV collagen levels in schistosomiasis mansoni. Arq. Gastroenterol. 2005, 42:221-225.
56. Zhang B.B., Cai W.M., Weng H.L., Hu Z.R., Lu J., Zheng M., Liu R.H. Diagnostic value of platelet derived growth factor-BB, transforming growth factor-beta1, matrix metalloproteinase-1, and tissue inhibitor of matrix metalloproteinase-1 in serum and peripheral blood mononuclear cells for hepatic fibrosis. World J. Gastroenterol. 2003, 9:2490-2496.
57. Zheng M., Cai W.M., Zhao J.K., Zhu S.M., Liu R.H. Determination of serum levels of YKL-40 and hyaluronic acid in patients with hepatic fibrosis due to schistosomiasis japonica and appraisal of their clinical value. Acta Trop. 2005, 96:148-152.